Literature DB >> 1676085

Vertical transmission of hepatitis C virus.

M M Thaler1, C K Park, D V Landers, D W Wara, M Houghton, G Veereman-Wauters, R L Sweet, J H Han.   

Abstract

There is evidence that hepatitis C virus (HCV) may be vertically transmitted from infected mothers to their children. To test this hypothesis, we prospectively studied 10 pregnant women at high risk from parenterally or sexually transmitted diseases with the polymerase chain reaction. HCV RNA was found in 8 newborn babies delivered by women who were anti-HCV seropositive, and persisted for 2-19 months of follow-up. Anti-HCV detected in 7 infants cleared by 9 months and remained undetectable thereafter. Serum alanine aminotransferase was raised in 3 infants. The findings provide evidence of vertical transmission of HCV and suggest that perinatal infection may initiate a silent disease process or chronic carrier state.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1676085     DOI: 10.1016/0140-6736(91)90006-b

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  36 in total

Review 1.  Hepatitis C in childhood.

Authors:  F Bortolotti
Journal:  Indian J Pediatr       Date:  1995 Sep-Oct       Impact factor: 1.967

2.  Vertical transmission of hepatitis C virus: an epidemiological study on 2,980 pregnant women in Italy.

Authors:  G Sabatino; L A Ramenghi; M di Marzio; E Pizzigallo
Journal:  Eur J Epidemiol       Date:  1996-10       Impact factor: 8.082

Review 3.  Hepatitis C: diagnosis and treatment.

Authors:  I Scotiniotis; C A Brass; P F Malet
Journal:  J Gen Intern Med       Date:  1995-05       Impact factor: 5.128

4.  HCV transmission in family members of subjects with HCV related chronic liver disease.

Authors:  L Demelia; E Vallebona; R Poma; G Sanna; G Masia; R C Coppola
Journal:  Eur J Epidemiol       Date:  1996-02       Impact factor: 8.082

5.  The prevalence of HCV infection in a cohort of pregnant women, the related risk factors and the possibility of vertical transmission.

Authors:  M Tanzi; E Bellelli; G Benaglia; E Cavatorta; A Merialdi; E Mordacci; M L Ribero; A Tagger; C Verrotti; A Volpicelli
Journal:  Eur J Epidemiol       Date:  1997-07       Impact factor: 8.082

Review 6.  Mode of hepatitis C virus infection, epidemiology, and chronicity rate in the general population and risk groups.

Authors:  H L Tillmann; M P Manns
Journal:  Dig Dis Sci       Date:  1996-12       Impact factor: 3.199

7.  Chronic non-A, non-B hepatitis: role of hepatitis C virus.

Authors:  R Iorio; S Guida; S Porzio; I Fariello; A Vegnente
Journal:  Arch Dis Child       Date:  1993-02       Impact factor: 3.791

Review 8.  Viral markers in the treatment of hepatitis B and C.

Authors:  H Schmilovitz-Weiss; M Levy; N Thompson; G Dusheiko
Journal:  Gut       Date:  1993       Impact factor: 23.059

9.  Storage conditions of blood samples and primer selection affect the yield of cDNA polymerase chain reaction products of hepatitis C virus.

Authors:  H T Cuypers; D Bresters; I N Winkel; H W Reesink; A J Weiner; M Houghton; C L van der Poel; P N Lelie
Journal:  J Clin Microbiol       Date:  1992-12       Impact factor: 5.948

Review 10.  Polymerase chain reaction for the diagnosis of viral hepatitis B and C.

Authors:  C Bréchot
Journal:  Gut       Date:  1993       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.